Lexicon Pharmaceuticals, Inc.
(NASDAQ : LXRX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-1.27%194.231.3%$534.82m
GILDGilead Sciences, Inc.
-0.56%65.800.9%$358.01m
ALXNAlexion Pharmaceuticals, Inc.
-3.46%104.102.0%$314.28m
ILMNIllumina, Inc.
0.95%301.103.5%$306.11m
BIIBBiogen Inc.
-1.81%234.381.3%$294.28m
CELGCelgene Corporation
0.12%98.721.3%$288.72m
AAgilent Technologies, Inc.
0.60%76.861.6%$174.39m
SRPTSarepta Therapeutics, Inc.
-2.67%82.6114.6%$174.08m
VRTXVertex Pharmaceuticals Incorporated
-1.25%173.801.9%$172.36m
REGNRegeneron Pharmaceuticals, Inc.
-2.01%282.322.6%$169.13m
EXASExact Sciences Corporation
-0.84%105.9724.1%$134.05m
ACADACADIA Pharmaceuticals Inc.
-2.72%41.4413.9%$111.84m
INCYIncyte Corporation
-1.31%78.072.5%$84.60m
BMRNBioMarin Pharmaceutical Inc.
0.08%75.064.3%$71.29m
ALDRAlder Biopharmaceuticals, Inc.
0.83%18.8610.2%$64.49m

Company Profile

Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. It drug candidates include XERMELO, Sotagliflozin, LX2761, and LX9211. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.